Sonoma Pharmaceuticals
SNOA
#10306
Rank
NZ$5.83 M
Marketcap
$3.61
Share price
-4.27%
Change (1 day)
-27.64%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -NZ$7.46 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$13.97 Million. a decrease over its 2023 earnings that were of -NZ$7.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$7.98 Million0.54%
2023 -NZ$7.94 Million-31.5%
2022 -NZ$11.58 Million16.86%
2021 -NZ$9.91 Million194.32%
2020 -NZ$3.37 Million-58.76%
2019 -NZ$8.17 Million-65.66%
2018 -NZ$23.78 Million4.84%
2017 -NZ$22.68 Million-2.17%
2016 -NZ$23.18 Million32.12%
2015 -NZ$17.55 Million-307.74%
2014 NZ$8.44 M-197.5%
2013 -NZ$8.67 Million
2010 -NZ$13.54 Million-14.02%
2009 -NZ$15.74 Million-57.28%
2008 -NZ$36.84 Million-8.03%
2007 -NZ$40.06 Million3.85%
2006 -NZ$38.57 Million39.31%
2005 -NZ$27.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$32.44 Million 306.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$18.52 Million 132.20%๐Ÿ‡บ๐Ÿ‡ธ USA